204 related articles for article (PubMed ID: 30071789)
21. Collagenase Clostridium histolyticum for the Treatment of Distal Interphalangeal Joint Contractures in Dupuytren Disease.
Fei TT; Chernoff E; Monacco NA; Komatsu DE; Muhlrad S; Sampson SP; Hurst LC; Dagum AB
J Hand Surg Am; 2019 May; 44(5):417.e1-417.e4. PubMed ID: 30146387
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of collagenase Clostridium histolyticum injection for Dupuytren's contracture in East-Asian population.
Hatta T; Goto H; Sonofuchi K; Itoi E
J Orthop Sci; 2019 May; 24(3):431-433. PubMed ID: 30392715
[TBL] [Abstract][Full Text] [Related]
23. Outcome of Dupuytren Contractures After Collagenase Clostridium Histolyticum Injection: A Single-institution Experience.
Hwee YK; Park D; Vinas M; Litts C; Friedman D
Ann Plast Surg; 2017 Aug; 79(2):145-148. PubMed ID: 28604542
[TBL] [Abstract][Full Text] [Related]
24. The use of Collagenase Clostridium Histolyticum in the management of Dupuytren's contracture-outcomes of a pilot study in a District General Hospital setting.
Murphy LE; Murphy KM; Kilpatrick SM; Thompson NW
Ulster Med J; 2017 May; 86(2):94-98. PubMed ID: 29535479
[TBL] [Abstract][Full Text] [Related]
25. Range of motion, postoperative rehabilitation and patient satisfaction in MCP and PIP joints affected by Dupuytren Tubiana stage 1-3: collagenase enzymatic fasciotomy or limited fasciectomy? A clinical study in 52 patients.
Leclère FM; Kohl S; Varonier C; Unglaub F; Vögelin E
Arch Orthop Trauma Surg; 2018 Nov; 138(11):1623-1631. PubMed ID: 30259125
[TBL] [Abstract][Full Text] [Related]
26. A comparison of percutaneous needle fasciotomy and collagenase injection for dupuytren disease.
Nydick JA; Olliff BW; Garcia MJ; Hess AV; Stone JD
J Hand Surg Am; 2013 Dec; 38(12):2377-80. PubMed ID: 24060510
[TBL] [Abstract][Full Text] [Related]
27. Five-Year Results of a Randomized, Controlled Trial of Collagenase Treatment Compared With Needle Fasciotomy for Dupuytren Contracture.
Byström M; Ibsen Sörensen A; Samuelsson K; Fridén JO; Strömberg J
J Hand Surg Am; 2022 Mar; 47(3):211-217. PubMed ID: 35074248
[TBL] [Abstract][Full Text] [Related]
28. Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
Hurst LC; Badalamente MA; Hentz VR; Hotchkiss RN; Kaplan FT; Meals RA; Smith TM; Rodzvilla J;
N Engl J Med; 2009 Sep; 361(10):968-79. PubMed ID: 19726771
[TBL] [Abstract][Full Text] [Related]
29. Adverse effects associated with collagenase clostridium histolyticum in Dupuytren disease: A prospective study.
Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P
Orthop Traumatol Surg Res; 2018 Oct; 104(6):901-905. PubMed ID: 30253866
[TBL] [Abstract][Full Text] [Related]
30. Determining clinically important changes in range of motion in patients with Dupuytren's Contracture: secondary analysis of the randomized, double-blind, placebo-controlled CORD I study.
Witthaut J; Bushmakin AG; Gerber RA; Cappelleri JC; Le Graverand-Gastineau MP
Clin Drug Investig; 2011 Nov; 31(11):791-8. PubMed ID: 21967070
[TBL] [Abstract][Full Text] [Related]
31. Three-Year Recurrence of Dupuytren Contracture after Needle Fasciotomy or Collagenase Injection: A Randomized Controlled Trial.
Jørgensen RW; Jensen CH; Jørring S
Plast Reconstr Surg; 2023 Feb; 151(2):365-371. PubMed ID: 36342689
[TBL] [Abstract][Full Text] [Related]
32. Short-term efficacy and safety of collagenase injection for Dupuytren's contracture: Therapy protocol for successful outcomes in a clinical setting.
Sakai A; Zenke Y; Menuki K; Yamanaka Y; Tajima T; Tsukamoto M; Uchida S
J Orthop Sci; 2019 May; 24(3):434-440. PubMed ID: 30392714
[TBL] [Abstract][Full Text] [Related]
33. Collagenase clostridium histolyticum in Dupuytren's contracture: a systematic review.
Smeraglia F; Del Buono A; Maffulli N
Br Med Bull; 2016 Jun; 118(1):149-58. PubMed ID: 27151958
[TBL] [Abstract][Full Text] [Related]
34. Collagenase injections for Dupuytren's contracture: prospective cohort study in a public health setting.
Fletcher J; Tan ESL; Thomas M; Taylor F; Elliott D; Bindra R
ANZ J Surg; 2019 May; 89(5):573-577. PubMed ID: 30685881
[TBL] [Abstract][Full Text] [Related]
35. Collagenase Treatment for Dupuytren Disease of the Thumb and First Web.
Dreise MM; Stenekes MW; Werker PM
J Hand Surg Am; 2016 Mar; 41(3):348-53.e1. PubMed ID: 26803569
[TBL] [Abstract][Full Text] [Related]
36. Prospective randomized controlled trial comparing 1- versus 7-day manipulation following collagenase injection for dupuytren contracture.
Mickelson DT; Noland SS; Watt AJ; Kollitz KM; Vedder NB; Huang JI
J Hand Surg Am; 2014 Oct; 39(10):1933-1941.e1. PubMed ID: 25194768
[TBL] [Abstract][Full Text] [Related]
37. The effect of a therapy protocol for increasing correction of severely contracted proximal interphalangeal joints caused by dupuytren disease and treated with collagenase injection.
Skirven TM; Bachoura A; Jacoby SM; Culp RW; Osterman AL
J Hand Surg Am; 2013 Apr; 38(4):684-9. PubMed ID: 23474162
[TBL] [Abstract][Full Text] [Related]
38. Collagenase Treatment of Dupuytren's Disease with Minimum 5-Year Follow-Up: Recurrence, Reintervention, and Satisfaction.
Zhang D; Earp BE; Benavent KA; Blazar P
Plast Reconstr Surg; 2020 Nov; 146(5):1071-1079. PubMed ID: 33136952
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of Recurrent Dupuytren Contracture Treatment.
Yoon AP; Kane RL; Hutton DW; Chung KC
JAMA Netw Open; 2020 Oct; 3(10):e2019861. PubMed ID: 33030553
[TBL] [Abstract][Full Text] [Related]
40. Durability of Collagenase Treatment for Dupuytren Disease of the Thumb and First Web After at Least 2 Years' Follow-Up.
Steenbeek LM; Dreise MM; Werker PMN
J Hand Surg Am; 2019 Aug; 44(8):694.e1-694.e5. PubMed ID: 30420196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
